US FDA approves Vera's kidney disease drug
US FDA approves Vera's kidney disease drug July 7 (Reuters) - The U.S. Food and Drug Administration has approved Vera Therapeutics' VERA.O drug to treat patients with a potentially life-threatening kidney disease, the regulator said on Tuesday.
(Reporting by Siddhi Mahatole and Puyaan Singh in Bengaluru; Editing by Vijay Kishore)
Recent news on Vera Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Forgent Power, Vera Bradley, Wells Fargo
U.S. STOCKS ON THE MOVE-Forgent Power, Vera Bradley, Wells Fargo
U.S. STOCKS ON THE MOVE-Eli Lilly, Waystar, Wells Fargo
U.S. STOCKS ON THE MOVE-Eli Lilly, Waystar, Sysco
Vera Therapeutics gains after kidney disease drug meets goals in confirmatory trial